falsefalse

My Treatment Approach: Graft vs Host Disease - Episode 5

Investigational Systemic Treatment Options for GVHD

Nelson J. Chao, MD, MBA, details some novel agents being developed for the systemic treatment of GVHD, particularly chronic GVHD.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Patient Profile Presentation: A 60-Year-Old Man with Graft-Versus-Host Disease (GVHD)
    EP. 2: Staging of Chronic GVHD
    EP. 3: First-Line Treatment Options for Patients with Chronic GVHD
    EP. 4: Patient Profile Presentation: A 67-Year-Old Woman with GVHD
    Now Viewing
    EP. 5: Investigational Systemic Treatment Options for GVHD
    EP. 6: Treatment Sequencing and Future of GVHD
    EP. 7: Patient Profile Presentation: A 44-Year-Old Woman With Acute Myeloid Leukemia and Graft-Versus-Host Disease (GVHD)
    EP. 8: Indications for Allogeneic Stem Cell Transplantation in the Treatment of Myeloid Malignancies
    EP. 9: Tailored Conditioning Regimens for Patients with GVHD Receiving Allogeneic Transplant
    EP. 10: Currently Available Options for GVHD Prophylaxis
    EP. 11: Comparing Acute and Chronic GVHD
    EP. 12: Available Frontline Treatment Options for Patients With Acute GVHD
    EP. 13: Current Treatment Options for Patients with Steroid-Refractory Acute GVHD

    Related Content:

    My Treatment Approach: Graft vs Host DiseaseInsightsInsights Video Series
    Looking Ahead: The Future of Care for NETs
    Managing NET Patients on Cabozantinib – Practical Insights
    Looking Ahead: Potential Sequencing Strategies and Focusing On a Patient-Centered Approach to Treatment of HER2-Mutated NSCLC
    x